Although existing research has begun to elucidate the expression profiles and molecular regulatory mechanisms of EIF3M in specific cancer types, a systematic understanding of its pan-cancer expression patterns, comprehensive biological functional landscape, and regulatory characteristics within signaling networks remains largely unexplored. This evidence concerns the gene EIF3M and cancer.